Republican Specialized Center of Cardiology , Tashkent, Uzbekistan
*Corresponding author: Feruza M. Bekmetova, PhD, Department of Coronary Heart Disease, Republican Specialized Center of Cardiology, 4, Osiyo str., 100052, Tashkent, Uzbekistan. Tel: 998-90-3276814. E-mail: email@example.com
Objective: To study the distribution of I/D polymorphic marker of the ACE gene in Uzbek patients with unstable angina, depending on the presence of family history of CHD compared with healthy individuals.
Materials and methods: There were examined 125 Uzbek patients with unstable angina (class IIB by E. Braunwald et al., 1989). In patients with unstable angina 63 patients (the 1st group) had and 62 patients (the 2nd group) had no a family history of CHD. Control group included 45 healthy Uzbek subjects without CHD and family history of CHD. The genomic DNA was isolated from the peripheral blood lymphocytes following standard protocol using the DiatomTM DNA Prep 200 kit (produced by LLC "Laboratory IsoGene"). I/D polymorphism of the ACE gene was detected according to Cambian F. et al. (1992).
Results: In a comparative analysis of both groups, patients showed similarity in the baseline clinical, hemodynamic and biochemical parameters; however, the 1st group had significant higher IMC thickness of the carotid arteries and hsCRP levels. Simultaneously, patients with a family history of CHD, compared with the healthy group of individuals, were noted to have a significantly higher prevalence of the D/D genotype [OR: 3.46 (95% CI: 1.18-8.11; P=0.035)] and "damaging" D-allele [OR: 2.47 (95% CI: 1.40-4.34; P=0.002)].
Conclusion: The presence of a family history of the coronary heart disease among Uzbek patients with unstable angina was associated with the higher frequency of the "damaging” D-allele of the ACE I/D gene polymorphism, accompanied by an increase in the thickness of the intima-media complex of the carotid arteries and level of high-sensitivity C-reactive protein.
- Devrishbekova ZM, Ivanchenko DN, Katelnitskaya LI. Genetically determined risk factors for myocardial infarction. Disease Prevention and Health Promotion 2008; 2: 9-12.
- Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: The Framingham Study. Am J Cardiol 1976; 38:46-51.
- Aronov DM. The system of angiotensin-converting enzyme - angiotensin II, atherosclerosis, and ACE inhibitors. Ter Arkh 2000; 12:5-7.
- Cambien F, Poirier O, Lecert L, et al. Deletion polymorphism in the gene of angiotensin-converting enzyme in a potent risk factor for myocardial infarction Nature 1992; 359:641-644.
- Taniguchi I, Yamazaki T, Wagatsuma К, et al. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J 2001; 65: 897-900.
- Buikema H, Pinto YM, Rooks G, et al. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17(5): 787-94.
- Tseluyko VI, Litvinova, IA, Kravchenko NA. Angiotensin-converting enzyme gene polymorphism in patients with hypertrophic cardiomyopathy. Ukrainian Journal of Cardiology 2000; 3: 37-41.
- Malygina NA, Kostomarova IV, Krivodubskaya TY, Muromova SI, et al. Analysis of the angiotensin-converting enzyme gene polymorphism in patients with coronary heart disease and hypertension. Kardiologiia 2000, 4:19-22.
- Van Geel PP, YM Pinto, AH Zwinderman, et al. Synergistic effects of angiotensin converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on ischaemic events. XX Congress of the European society of Cardiology 2001; Abstract 386.
- Lozano T, Ena J, Almenar V, Graells M, Molina J, Antorrena I, de la Guía F. Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high-sensitivity C-reactive protein. Rev Esp Cardiol 2007; 60(8):817-24
- Haverkate F, Thompson S, Pyke S. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349:462-466
The fully formatted PDF version is available.
Int J Biomed. 2012; 2(4):275-278. © 2012 International Medical Research and Development Corporation. All rights reserved.